Bristol-Myers Squibb

Can Merck Keytruda Crawl Back Above Bristol-Myers Opdivo?
Bidness, ETC
Sat, 12/19/15 - 11:36 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Glaxo to Pay Bristol-Myers Up to $1.46 Billion for HIV Drugs
Bloomberg
Fri, 12/18/15 - 08:45 am
GSK
Bristol-Myers Squibb
HIV
ViiV Healthcare
Bristol's drug pricing under fire as UK agency rejects Opdivo
Yahoo/Reuters
Wed, 12/16/15 - 10:07 am
Bristol-Myers Squibb
UK
Opdivo
NICE
Bristol Myers’s Empliciti Receives FDA Approval
Yahoo/Market Realist
Tue, 12/15/15 - 09:47 am
Bristol-Myers Squibb
Empliciti
FDA
Multiple Myeloma
Bristol-Myers Squibb and UCLA Enter into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Research Program
Yahoo
Mon, 12/14/15 - 11:01 am
Bristol-Myers Squibb
UCLA
R&D
immuno-oncology
Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds
Yahoo/Benzinga
Sun, 12/13/15 - 11:13 am
Bristol-Myers Squibb
AbbVie
Merck
Eli Lilly
Zoetis
Bayer looks to bone up in oncology after slipping behind rivals
Fierce Biotech
Sat, 12/12/15 - 01:51 pm
Bayer
oncology
Bristol-Myers Squibb
Merck
R&D
With Paris spotlight on climate change, here's how Big Pharma stacks up
Fierce Pharma
Wed, 12/9/15 - 11:46 am
climate change
Sanofi
Biogen
Novo Nordisk
JNJ
Pfizer
Merck
Eli Lilly
Shire
Roche
Bristol-Myers Squibb
Can Bristol-Myers Squibb And AbbVie's Empliciti Become a Top Seller?
Motley Fool
Tue, 12/1/15 - 01:18 pm
AbbVie
Bristol-Myers Squibb
Empliciti
Multiple Myeloma
Bristol-Myers Squibb's Opdivo May Change How We Treat Pancreatic Cancer
Motley Fool
Sun, 11/29/15 - 12:36 pm
Bristol-Myers Squibb
Opdivo
pancreatic cancer
FDA declines expanded approval for Bristol-Myers' Opdivo drug
Yahoo/Reuters
Fri, 11/27/15 - 05:48 pm
FDA
Bristol-Myers Squibb
Opdivo
melanoma
FDA approves expanded use of Bristol-Myers' skin cancer drug
Yahoo/Reuters
Tue, 11/24/15 - 01:52 pm
FDA
Bristol-Myers Squibb
melanoma
Opdivo
Bristol-Myers Lets Low-Income Countries Copy Hepatitis C Pills
Bloomberg
Mon, 11/23/15 - 10:14 am
Bristol-Myers Squibb
hepatitis C
Medicines Patent Pool
Daklinza
Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer
Motley Fool
Sun, 11/22/15 - 10:47 am
chemotherapy
cancer immunotherapies
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
targeted therapies
Pfizer
Xalkori
stem cells
OncoMed
tumor hypoxia
Threshold Pharmaceuticals
Big pharma trying to quash CA drug price cap effort with massive campaign war chest
BioPharma Dive
Fri, 11/20/15 - 10:55 am
California
drug pricing
JNJ
AbbVie
Amgen
Eli Lilly
Bristol-Myers Squibb
AbbVie's Humira repeats, joined by BMS' Opdivo in leading TV spending for October
Fierce Pharma Marketing
Wed, 11/18/15 - 09:42 am
AbbVie
Humira
Bristol-Myers Squibb
Opdivo
drug ads
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Fierce Pharma
Tue, 11/17/15 - 05:57 pm
Bristol-Myers Squibb
FDA
priority review
Opdivo
kidney cancer
One Reason We Think Biotech Has Bottomed
Seeking Alpha
Sun, 11/8/15 - 11:49 am
biotech
Allergan
AstraZeneca
Bristol-Myers Squibb
Celgene
Gilead Sciences
Horizon Pharma
Insys
Pfizer
Retrophin
Valeant Pharmaceuticals
ZS Pharma
Bristol-Myers Leads the Pack in Immuno-Oncology; Credit Suisse Sees $10.5B in 2020 Sales
Barron's
Tue, 11/3/15 - 05:50 pm
Bristol-Myers Squibb
immuno-oncology
Bristol-Myers buys private drugmaker to boost heart treatment pipeline
Yahoo/Reuters
Mon, 11/2/15 - 08:22 am
Bristol-Myers Squibb
Cardioxyl
CXL-1427
M&A

Pages